Myers Scott Dunseth 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Nov 13, 2024
Insider Transaction Report
Form 4
Myers Scott Dunseth
Director
Transactions
- Award
Common Stock
2024-11-13+260,192→ 260,192 total
Footnotes (1)
- [F1]The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.